|
Volumn 311, Issue 21, 2014, Pages 2235-
|
Guidelines for cardiovascular risk assessment and cholesterol treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
BLOOD PRESSURE MONITORING;
CARDIOVASCULAR DISEASE;
DECISION MAKING;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HUMAN;
HYPERCHOLESTEROLEMIA;
LETTER;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
FEMALE;
MALE;
NOTE;
PATIENT CARE;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
MALE;
PATIENT-CENTERED CARE;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 84901781616
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.4072 Document Type: Letter |
Times cited : (8)
|
References (5)
|